Safety Study of TAK-593 Given Orally in Subjects With Nonhematologic Advanced Cancer
Clinical trial NCT00773929 · COMPLETED
Trial details
- NCT number
- NCT00773929
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2010-01-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.